Barclays
DVAX

Barclays’s Dynavax Technologies DVAX Stock Holding History

Barclays’s Portfolio DVAX Stock Details DVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-16,400
Closed -$326K – 7024
2018
Q1 		$326K Buy
+16,400
New +$283K ﹤0.01% 4386
2016
Q1 		– Sell
-6,100
Closed -$146K – 6201
2015
Q4 		$146K Buy
+6,100
New +$153K ﹤0.01% 4146

Other funds holding DVAX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Barclays's DVAX Position: Q1 2026 in Review

Barclays sold out of Dynavax Technologies (DVAX) in Q1 2026, closing a stake of 317,848 shares — an estimated $4.89M sold.

Barclays first reported a position in DVAX in Q2 2013 and held it in 48 quarters. The position peaked at $5.63M in Q4 2023. 1 fund tracked by Wall St. Rank holds DVAX as of Q1 2026.

  • Barclays reported no remaining Dynavax Technologies position as of Q1 2026 after selling out during the quarter.
  • Barclays sold 317,848 Dynavax Technologies shares in Q1 2026, an estimated $4.89M.
  • Barclays first reported a position in Dynavax Technologies in Q2 2013 and held it in 48 quarters.
  • Barclays's Dynavax Technologies position peaked at $5.63M in Q4 2023.
  • 1 fund tracked by Wall St. Rank held Dynavax Technologies as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.